These studies, while promising, cannot fully predict how the peptide will behave in human systems
When those conditions change, the molecule can unfold, aggregate, or degrade into fragments that no longer activate your GLP-1 receptors
Key considerations for B12 intravenous dosing include: Initial dose: 1,000 mcg per infusion Frequency of administration: varies based on clinical need Monitoring of patient response to adjust dosing as necessary IV Infusion Methods and Duration B12 IV infusions are given slowly to avoid side effects
For Ochratoxin A, prescription binders like Cholestyramine (CSM) or Colesevelam (Welchol) are considered the gold standard in the Shoemaker Protocol, though natural binders like activated charcoal and glucomannan are also highly effective
it was proven that Aflatoxin B1, Ochratoxin A and Sterigmatocystin are strong carcinogens (17)